P2175
The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patientsOral zinc for the prevention of hyperbilirubinaemia in neonatesUse of reflective materials during phototherapy for newborn infants with unconjugated hyperbilirubinaemiaFluid supplementation for neonatal unconjugated hyperbilirubinaemiaPeriodic change of body position under phototherapy in term and late preterm neonates with hyperbilirubinemiaTranscutaneous screening for hyperbilirubinemia in neonatesEffect of pre-exchange albumin infusion on neonatal hyperbilirubinaemia and long-term developmental outcomesClofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemiaLight-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonatesClofibrate alongside phototherapy for unconjugated neonatal hyperbilirubinaemiaOral zinc for the prevention of hyperbilirubinemia in neonatesLight-emitting diode phototherapy for unconjugated hyperbilirubinemia in neonatesMetalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonatesEffect of dietary composition on the unconjugated hyperbilirubinaemia of Gilbert's syndromeLifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vectorHepatobiliary transport of glutathione and glutathione conjugate in rats with hereditary hyperbilirubinemiaCommon variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemiaHyperbilirubinaemia after major thoracic surgery: comparison between open-heart surgery and oesophagectomyHyperbilirubinemia in Neonates: Types, Causes, Clinical Examinations, Preventive Measures and Treatments: A Narrative Review ArticleFacility-based constraints to exchange transfusions for neonatal hyperbilirubinemia in resource-limited settingsTherapeutic Efficacy and Safety of Paeoniae Radix Rubra Formulae in Relieving Hyperbilirubinemia Induced by Viral Hepatitis: A Meta-AnalysisClofibrate for unconjugated hyperbilirubinemia in neonates: a systematic reviewEtiologies of conjugated hyperbilirubinemia in infancy: a systematic review of 1692 subjectsThe impact of SLCO1B1 genetic polymorphisms on neonatal hyperbilirubinemia: a systematic review with meta-analysisEvaluation and treatment of neonatal hyperbilirubinemiaPatients with Advanced Pancreatic Cancer and Hyperbilirubinaemia: Review and German Expert Opinion on Treatment with nab-Paclitaxel plus GemcitabineRisk factors for severe neonatal hyperbilirubinemia in low and middle-income countries: a systematic review and meta-analysisRadixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranesGenetic factors related to unconjugated hyperbilirubinemia amongst adultsMutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndromeRisk factors for severe hyperbilirubinemia in neonatesPlasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemiaHyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome)Two distinct mechanisms for bilirubin glucuronide transport by rat bile canalicular membrane vesicles. Demonstration of defective ATP-dependent transport in rats (TR-) with inherited conjugated hyperbilirubinemiaErythrocyte membrane transport of glutathione conjugates and oxidized glutathione in the Dubin-Johnson syndrome and in rats with hereditary hyperbilirubinemiaExcretion of D-glucaric-acid in newborns with non-hemolytic hyperbilirubinemia after phenobarbital treatment (author's transl)Defective biliary secretion of bile acid 3-O-glucuronides in rats with hereditary conjugated hyperbilirubinemiaEffect of phototherapy on the urinary excretion of tryptophan metabolites in neonatal hyperbilirubinemiaIdentifying newborns at risk of significant hyperbilirubinaemia: a comparison of two recommended approaches
P921
Q21559550-FC638DB2-8B45-49E8-BB99-CEEA6C224BCCQ24186480-A34EFBCC-E758-4331-99A9-93635AA5AFA6Q24187410-E64D1711-1B0B-4CE8-9590-12320ECC8C63Q24187463-D5FEDE8D-3FDD-44B8-AD7C-086B71A7AF1FQ24187506-5CBDBE58-9DE0-48F1-8B61-C79E02A9A61DQ24197660-3F869648-DDB4-483D-BFBE-B376E92AD769Q24200720-F82FC23C-F106-4392-B5FD-3BA9782FC16FQ24202400-9B460E3A-1282-4E69-B5DB-48D90B18F629Q24204037-38203A99-44ED-4160-B288-FF42881D164AQ24236461-C5EB582A-70FE-4FA1-B370-6F9065C5C375Q24239861-61CAD786-02F8-4107-B450-882AEFEDB71BQ24240932-A5EAFE4F-5C45-4BC0-AF29-ABA13CB5662DQ24250212-64B3494F-77CA-48D3-A6E0-CCD6CC9D5D6DQ24541381-302441E2-1349-40A5-8204-C8F6FD0DEA2EQ24555782-CE97D6F1-6E79-4D7D-AF15-2E0BB7D49851Q24556652-DFF4AC4A-93B7-455F-8488-474D60115E0DQ24658145-E5567AF2-DE1B-4922-849E-9CC28EC3BFD2Q24794748-62C2D508-F290-47D0-BCB3-3BF00678DC59Q26741363-F34CDF57-97E3-4F1C-BC2E-96869CA9A461Q26750484-6C07A059-C34F-4DFD-B2C8-B7863A54CF2AQ26752392-F21462F2-3CCC-4C36-8AC5-0706B1BBD3CFQ26825291-BD02D832-7592-4156-A2D9-A2B6350A6E9AQ27008433-B60A4530-D19C-44BE-96A8-A67A4EC5760EQ27013043-D65B31DD-E61A-421C-8799-BB966CB839E8Q27027654-884289C6-64F0-4BFA-9827-CFFB540570EAQ28083215-E6CAE7C8-CB16-4FE8-8C78-1D7ECCCB3C3CQ28083635-F46F4BDB-C308-4BC1-9BF8-2056A84D2F07Q28204937-85599148-560E-435E-80C5-AE2FD46B073BQ28247873-38B7FE8E-1A13-4F43-B5FC-A1973ABC4A0CQ28258556-22EDC4C1-DE7C-46FD-A565-4A92B8E509A5Q28277932-DB517D72-22A0-4220-BFDE-4E8ECE2DC2C5Q28286926-B900AA16-0C08-4320-9EEE-562813D15CB3Q28292517-FCAFA5CF-4802-4940-8700-C4CC546AA430Q28295988-B4D7BE02-34F8-4E6E-A80C-15C89054E032Q28317256-36614253-DF46-4F29-9A59-C873B8B7A168Q28319291-197FA4DE-48B6-4C2F-BC43-C4748FD7DBB1Q28332907-1EC61796-F158-4AFE-9CBE-616188223912Q28341692-00F4304D-DC2B-4E65-9739-1BEAF1D7C39CQ28341726-EA324E71-9E89-4517-97F0-D92B3FA0A54EQ28764469-4C809242-095D-49BD-8FE0-6B5DEED4E816
P921
description
Krankheit
@de
gruppo di malattie metaboliche ...... ia, è dovuto a cause genetiche
@it
inherited metabolic disorder t ...... uption of bilirubin metabolism
@en
name
anhwylder metabolig bilirwbin
@cy
bilirubin metabolic disorder
@en
forstyrring i bilirubinmetabolismen
@nn
hyperbilirubinémie héréditaire
@fr
iperbilirubinemie ereditarie
@it
trastorn metabòlic de la bilirubina
@ca
trastorno metabólico de la bilirrubina
@es
type
label
anhwylder metabolig bilirwbin
@cy
bilirubin metabolic disorder
@en
forstyrring i bilirubinmetabolismen
@nn
hyperbilirubinémie héréditaire
@fr
iperbilirubinemie ereditarie
@it
trastorn metabòlic de la bilirubina
@ca
trastorno metabólico de la bilirrubina
@es
altLabel
hereditary hyperbilirubinemia
@en
hyperbilirubinaemia
@en
hyperbilirubinemia
@en
trastorn del metabolisme de la bilirubina
@ca
trastorno del metabolismo de la bilirrubina
@es
prefLabel
anhwylder metabolig bilirwbin
@cy
bilirubin metabolic disorder
@en
forstyrring i bilirubinmetabolismen
@nn
hyperbilirubinémie héréditaire
@fr
iperbilirubinemie ereditarie
@it
trastorn metabòlic de la bilirubina
@ca
trastorno metabólico de la bilirrubina
@es
P486
P6366
P1748
P1995
P2176
P2892
P31
P486
P6366
2778814936
P672
C16.320.565.300
C18.452.648.300